Select a community
Mood Conditions including Depression, Anxiety, Bipolar, OCD, and PTSD
Find out more about the PatientsLikeMe
Mood Conditions Community
Home > Community Treatment Reports > Triamcinolone Treatment Report
What is Triamcinolone?

Triamcinolone is used to treat the itching, redness, dryness, crusting, scaling, inflammation, and discomfort of various skin conditions. It is also used to relieve the discomfort of mouth sores. It is available in a spray, inhalant, oral and topical preparations.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken
# of patients Efficacy
Major
Moderate
Slight
None
Can’t tell 		# of patients evaluated by
Allergies 2 1
Rhinitis (nasal inflammation) 1 0
disfunctional eustacheon tube 1 0

See all 3 patients currently taking Triamcinolone

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
1 100%
Mild
0 0%
None
0 0%

Most commonly reported side effects

Stomach upset
1 100%
  • Mild
  • Moderate
  • Severe

Dosages

  55 mcg daily 110 mcg daily
  1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Triamcinolone (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other
2 100% Other: 100%

See all 2 patients who’ve stopped taking Triamcinolone

Duration See details about how long patients take this treatment ▼

Currently Taking Triamcinolone

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Triamcinolone

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
0 0%
Usually
1 100%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
1 100%
Not at all
0 0%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on March 20, 2010.